Virulence and thrombocyte affectation of two Aspergillus terreus isolates differing in amphotericin B susceptibility

Medical Microbiology and Immunology

Volumn 202, Issue 5, 2013, Pages 379-389

  Speth, Cornelia ^a   Blum, Gerhard ^a   Hagleitner, Magdalena ^a   Hörtnagl, Caroline ^a   Pfaller, Kristian ^a   Posch, Beate ^a   Ott, Helmut Werner ^a   Würzner, Reinhard ^a   Lass Flörl, Cornelia ^a   Rambach, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Aspergillus; Fungal infection; Pathogenesis; Thrombocytes; Virulence

Indexed keywords

AMPHOTERICIN B; PHOSPHATIDYLSERINE; SERINE PROTEINASE;

ALEURIOSPORE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS TERREUS; CONIDIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNGAL STRUCTURES; FUNGAL VIRULENCE; FUNGUS HYPHAE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INVASIVE ASPERGILLOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STRAIN DIFFERENCE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE COUNT;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; BLOOD PLATELETS; CELL ADHESION; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, FUNGAL; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MICE; MICE, INBRED BALB C; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; VIRULENCE;

EID: 84885671350     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-013-0300-7     Document Type: Article

References (36)

1. Fridkin S (2005) The changing face of fungal infections in health care settings. Clin Infect Dis 41:1455-1460
2. Martino R, Subira M (2002) Invasive fungal infections in hematology: new trends. Ann Hematol 81:233-243
3. Singh N (2001) Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis 33:1692-1696
4. Patel DA, Gao X, Stephens JM, Forshag MS, Tarallo M (2011) US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host. J Med Econ 14:227-237
5. Ader F (2010) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease. Curr Infect Dis Rep 12:409-416
6. Steinbach W, Benjamin D, Kontoyiannis D, Perfect J, Lutsar I, Marr K, Lionakis M, Torres H, Jafri H, Walsh T (2004) Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 39:192-198
7. Anaissie E (1992) Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 14(Suppl 1):43-53
8. Lass-Flörl C, Rath PM, Niederwieser D, Kofler G, Würzner R, Kreczy A, Dierich MP (2000) Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J Hosp Infect 46:31-35
9. Lass- Flörl C, Grif K, Kontoyiannis DP (2007) Molecular typing of Aspergillus terreus isolates in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol 45:2686-2690
10. Blum G, Perkhofer S, Grif K, Mayr A, Kropshofer G, Nachbaur D, Kafka-Ritsch R, Dierich MP, Lass-Florl C (2008) A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infect 14:1146-1151
11. Abraham O, Manavathu E, Cutright JL, Chandrasekar PH (1999) In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B. Diagn Microbiol Infect Dis 33:7-11
12. Espinel-Ingroff A, Arthington-Skaggs BA, Igbal N, Ellis D, Pfaller M, Messer SA, Rinaldi M, Fothergill A, Gibbs D, Wang A (2007) A multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin-B and caspofungin. J Clin Microbiol 45:1811-1820
13. Lass-Flörl C, Rief A, Leitner S, Speth C, Wurzner R, Dierich M (2005) In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus. Antimicrob Agents Chemother 49:2539-2540
14. Vanden Bossche H, Warnock DW, Dupont B, Kerridge D, Sen GS, Improvisi L, Marichal P, Odds FC, Provost F, Ronin O (1994) Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol 32(Suppl 1):189-202
15. Blum G, Kainzner B, Grif K, Dietrich H, Zelger B, Sonnweber T, Lass-Florl C (2013) In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus. Clin Microbiol Infect 19:50-55
16. Blum G, Hortnagl C, Jukic E, Erbeznik T, Pumpel T, Dietrich H, Nagl M, Speth C, Rambach G, Lass-Florl C (2013) New insight into amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother 57:1583-1588
17. Lass-Flörl C, Griff K, Mayr A, Petzer A, Bonatti H, Freund M, Kropshofer G, Dierich MP, Nachbaur D (2005) Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 131:201-207
18. Leslie M (2010) Cell biology. Beyond clotting: the powers of platelets. Science 328:562-564
19. Yeaman MR, Bayer AS (2006) Antimicrobial peptides versus invasive infections. Curr Top Microbiol Immunol 306:111-152
20. Dachary-Prigent J, Toti F, Satta N, Pasquet JM, Uzan A, Freyssinet JM (1996) Physiopathological significance of catalytic phospholipids in the generation of thrombin. Semin Thromb Hemost 22:157-164
21. Hearn V, Wilson E, Mackenzie D (1980) The preparation of protoplasts from Aspergillus fumigatus mycelium. Sabouraudia 18:75-77
22. Peberdy JF, Buckley CE, Daltrey DC, Moore PM (1976) Factors affecting protoplast release in some filamentous fungi. Trans British Mycol Soc 67:23-26
23. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
24. Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF (1982) Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122:429-436
25. Deak E, Wilson SD, White E, Carr JH, Balajee SA (2009) Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics. PLoS ONE 4:e7673
26. Speth C, Hagleitner M, Ott HW, Wurzner R, Lass-Florl C, Rambach G (2013) Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds. J Infect Dis 207:823-833
27. Blum G, Hortnagl C, Jukic E, Erbeznik T, Pumpel T, Dietrich H, Nagl M, Speth C, Rambach G, Lass-Florl C (2013) New insight into Amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother
28. Latge P (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12:310-350
29. Christin L, Wysong DR, Meshulam T, Hastey R, Simons ER, Diamond RD (1998) Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun 66:1181-1189
30. Perkhofer S, Kehrel BE, Dierich MP, Donnelly JP, Nussbaumer W, Hofmann J, von EC, Lass-Florl C (2008) Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J Infect Dis 198:1243-1246
31. Rodland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Froland SS (2010) Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis. Infect Immun 78:1269-1275
32. Li Z, Yang F, Dunn S, Gross AK, Smyth SS (2011) Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res 127:184-188
33. Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264-274
34. Morel O, Jesel L, Freyssinet JM, Toti F (2011) Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 31:15-26
35. Maugeri N, Rovere-Querini P, Evangelista V, Covino C, Capobianco A, Bertilaccio MT, Piccoli A, Totani L, Cianflone D, Maseri A, Manfredi AA (2009) Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood 113:5254-5265
36. Michelson AD (2011) Advances in antiplatelet therapy. Hematol Am Soc Hematol Educ Program 2011:62-69